Medical Care
Next Generation Sequencing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Sep 11, 24
- ID: 548006
- Pages: 110
- Figures: 183
- Views: 1
Next Generation Sequencing (NGS) is a high-throughput method for rapid sequencing of base pairs of DNA or RNA samples.
The global market for Next Generation Sequencing was estimated to be worth US$ 3690.2 million in 2023 and is forecast to a readjusted size of US$ 4686.3 million by 2030 with a CAGR of 3.4% during the forecast period 2024-2030
The classification of Next-Generation Sequencing (NGS) Services includes Targeted Sequencing, Whole Exome Sequencing and Whole Genome Sequencing, and the proportion of Targeted Sequencing in 2019 is about 55%.
Next-Generation Sequencing (NGS) Services is widely used in Hospitals and Clinics, Biopharma Companies, Academic & Research Organizations and Other. The most proportion of Next-Generation Sequencing (NGS) Services is Hospitals and Clinics, and the proportion in 2019 is about 56%.
North America is the largest consumption place, with a consumption market share nearly 37% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of about 32%.
Eurofins Scientific, Natera, BGI, Illumina, etc. are the leaders of the industry.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Next Generation Sequencing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Next Generation Sequencing by region & country, by Type, and by Application.
The Next Generation Sequencing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next Generation Sequencing.
Market Segmentation
By Company
454 Life Sciences Corporation (A Roche Company)
Agilent Technologies
Biomatters, Ltd
CLC Bio
GATC biotech AG
Macrogen
BGI (Beijing Genomics Institute)
Illumina
Life Technology Corporation
EMC Corporation
Dnastar
Segment by Type:
Targeted Sequencing & Resequencing
Whole Genome Sequencing
Whole Exome Sequencing
Segment by Application
Whole-genome Sequencing
Exome Sequencing
Targeted Resequencing
De Novo Sequencing
RNA Sequencing
ChIP Sequencing
Methyl Sequencing
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Next Generation Sequencing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Next Generation Sequencing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Next Generation Sequencing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for Next Generation Sequencing was estimated to be worth US$ 3690.2 million in 2023 and is forecast to a readjusted size of US$ 4686.3 million by 2030 with a CAGR of 3.4% during the forecast period 2024-2030
The classification of Next-Generation Sequencing (NGS) Services includes Targeted Sequencing, Whole Exome Sequencing and Whole Genome Sequencing, and the proportion of Targeted Sequencing in 2019 is about 55%.
Next-Generation Sequencing (NGS) Services is widely used in Hospitals and Clinics, Biopharma Companies, Academic & Research Organizations and Other. The most proportion of Next-Generation Sequencing (NGS) Services is Hospitals and Clinics, and the proportion in 2019 is about 56%.
North America is the largest consumption place, with a consumption market share nearly 37% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of about 32%.
Eurofins Scientific, Natera, BGI, Illumina, etc. are the leaders of the industry.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Next Generation Sequencing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Next Generation Sequencing by region & country, by Type, and by Application.
The Next Generation Sequencing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next Generation Sequencing.
Market Segmentation
By Company
454 Life Sciences Corporation (A Roche Company)
Agilent Technologies
Biomatters, Ltd
CLC Bio
GATC biotech AG
Macrogen
BGI (Beijing Genomics Institute)
Illumina
Life Technology Corporation
EMC Corporation
Dnastar
Segment by Type:
Targeted Sequencing & Resequencing
Whole Genome Sequencing
Whole Exome Sequencing
Segment by Application
Whole-genome Sequencing
Exome Sequencing
Targeted Resequencing
De Novo Sequencing
RNA Sequencing
ChIP Sequencing
Methyl Sequencing
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Next Generation Sequencing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Next Generation Sequencing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Next Generation Sequencing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Next Generation Sequencing Product Introduction
1.2 Global Next Generation Sequencing Market Size Forecast
1.3 Next Generation Sequencing Market Trends & Drivers
1.3.1 Next Generation Sequencing Industry Trends
1.3.2 Next Generation Sequencing Market Drivers & Opportunity
1.3.3 Next Generation Sequencing Market Challenges
1.3.4 Next Generation Sequencing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Next Generation Sequencing Players Revenue Ranking (2023)
2.2 Global Next Generation Sequencing Revenue by Company (2019-2024)
2.3 Key Companies Next Generation Sequencing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Next Generation Sequencing Product Offered
2.5 Key Companies Time to Begin Mass Production of Next Generation Sequencing
2.6 Next Generation Sequencing Market Competitive Analysis
2.6.1 Next Generation Sequencing Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Next Generation Sequencing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Sequencing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Targeted Sequencing & Resequencing
3.1.2 Whole Genome Sequencing
3.1.3 Whole Exome Sequencing
3.2 Global Next Generation Sequencing Sales Value by Type
3.2.1 Global Next Generation Sequencing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Next Generation Sequencing Sales Value, by Type (2019-2030)
3.2.3 Global Next Generation Sequencing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Whole-genome Sequencing
4.1.2 Exome Sequencing
4.1.3 Targeted Resequencing
4.1.4 De Novo Sequencing
4.1.5 RNA Sequencing
4.1.6 ChIP Sequencing
4.1.7 Methyl Sequencing
4.1.8 Others
4.2 Global Next Generation Sequencing Sales Value by Application
4.2.1 Global Next Generation Sequencing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Next Generation Sequencing Sales Value, by Application (2019-2030)
4.2.3 Global Next Generation Sequencing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Next Generation Sequencing Sales Value by Region
5.1.1 Global Next Generation Sequencing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Next Generation Sequencing Sales Value by Region (2019-2024)
5.1.3 Global Next Generation Sequencing Sales Value by Region (2025-2030)
5.1.4 Global Next Generation Sequencing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Next Generation Sequencing Sales Value, 2019-2030
5.2.2 North America Next Generation Sequencing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Next Generation Sequencing Sales Value, 2019-2030
5.3.2 Europe Next Generation Sequencing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Next Generation Sequencing Sales Value, 2019-2030
5.4.2 Asia Pacific Next Generation Sequencing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Next Generation Sequencing Sales Value, 2019-2030
5.5.2 South America Next Generation Sequencing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Next Generation Sequencing Sales Value, 2019-2030
5.6.2 Middle East & Africa Next Generation Sequencing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Next Generation Sequencing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Next Generation Sequencing Sales Value
6.3 United States
6.3.1 United States Next Generation Sequencing Sales Value, 2019-2030
6.3.2 United States Next Generation Sequencing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Next Generation Sequencing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Next Generation Sequencing Sales Value, 2019-2030
6.4.2 Europe Next Generation Sequencing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Next Generation Sequencing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Next Generation Sequencing Sales Value, 2019-2030
6.5.2 China Next Generation Sequencing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Next Generation Sequencing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Next Generation Sequencing Sales Value, 2019-2030
6.6.2 Japan Next Generation Sequencing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Next Generation Sequencing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Next Generation Sequencing Sales Value, 2019-2030
6.7.2 South Korea Next Generation Sequencing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Next Generation Sequencing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Next Generation Sequencing Sales Value, 2019-2030
6.8.2 Southeast Asia Next Generation Sequencing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Next Generation Sequencing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Next Generation Sequencing Sales Value, 2019-2030
6.9.2 India Next Generation Sequencing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Next Generation Sequencing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 454 Life Sciences Corporation (A Roche Company)
7.1.1 454 Life Sciences Corporation (A Roche Company) Profile
7.1.2 454 Life Sciences Corporation (A Roche Company) Main Business
7.1.3 454 Life Sciences Corporation (A Roche Company) Next Generation Sequencing Products, Services and Solutions
7.1.4 454 Life Sciences Corporation (A Roche Company) Next Generation Sequencing Revenue (US$ Million) & (2019-2024)
7.1.5 454 Life Sciences Corporation (A Roche Company) Recent Developments
7.2 Agilent Technologies
7.2.1 Agilent Technologies Profile
7.2.2 Agilent Technologies Main Business
7.2.3 Agilent Technologies Next Generation Sequencing Products, Services and Solutions
7.2.4 Agilent Technologies Next Generation Sequencing Revenue (US$ Million) & (2019-2024)
7.2.5 Agilent Technologies Recent Developments
7.3 Biomatters, Ltd
7.3.1 Biomatters, Ltd Profile
7.3.2 Biomatters, Ltd Main Business
7.3.3 Biomatters, Ltd Next Generation Sequencing Products, Services and Solutions
7.3.4 Biomatters, Ltd Next Generation Sequencing Revenue (US$ Million) & (2019-2024)
7.3.5 CLC Bio Recent Developments
7.4 CLC Bio
7.4.1 CLC Bio Profile
7.4.2 CLC Bio Main Business
7.4.3 CLC Bio Next Generation Sequencing Products, Services and Solutions
7.4.4 CLC Bio Next Generation Sequencing Revenue (US$ Million) & (2019-2024)
7.4.5 CLC Bio Recent Developments
7.5 GATC biotech AG
7.5.1 GATC biotech AG Profile
7.5.2 GATC biotech AG Main Business
7.5.3 GATC biotech AG Next Generation Sequencing Products, Services and Solutions
7.5.4 GATC biotech AG Next Generation Sequencing Revenue (US$ Million) & (2019-2024)
7.5.5 GATC biotech AG Recent Developments
7.6 Macrogen
7.6.1 Macrogen Profile
7.6.2 Macrogen Main Business
7.6.3 Macrogen Next Generation Sequencing Products, Services and Solutions
7.6.4 Macrogen Next Generation Sequencing Revenue (US$ Million) & (2019-2024)
7.6.5 Macrogen Recent Developments
7.7 BGI (Beijing Genomics Institute)
7.7.1 BGI (Beijing Genomics Institute) Profile
7.7.2 BGI (Beijing Genomics Institute) Main Business
7.7.3 BGI (Beijing Genomics Institute) Next Generation Sequencing Products, Services and Solutions
7.7.4 BGI (Beijing Genomics Institute) Next Generation Sequencing Revenue (US$ Million) & (2019-2024)
7.7.5 BGI (Beijing Genomics Institute) Recent Developments
7.8 Illumina
7.8.1 Illumina Profile
7.8.2 Illumina Main Business
7.8.3 Illumina Next Generation Sequencing Products, Services and Solutions
7.8.4 Illumina Next Generation Sequencing Revenue (US$ Million) & (2019-2024)
7.8.5 Illumina Recent Developments
7.9 Life Technology Corporation
7.9.1 Life Technology Corporation Profile
7.9.2 Life Technology Corporation Main Business
7.9.3 Life Technology Corporation Next Generation Sequencing Products, Services and Solutions
7.9.4 Life Technology Corporation Next Generation Sequencing Revenue (US$ Million) & (2019-2024)
7.9.5 Life Technology Corporation Recent Developments
7.10 EMC Corporation
7.10.1 EMC Corporation Profile
7.10.2 EMC Corporation Main Business
7.10.3 EMC Corporation Next Generation Sequencing Products, Services and Solutions
7.10.4 EMC Corporation Next Generation Sequencing Revenue (US$ Million) & (2019-2024)
7.10.5 EMC Corporation Recent Developments
7.11 Dnastar
7.11.1 Dnastar Profile
7.11.2 Dnastar Main Business
7.11.3 Dnastar Next Generation Sequencing Products, Services and Solutions
7.11.4 Dnastar Next Generation Sequencing Revenue (US$ Million) & (2019-2024)
7.11.5 Dnastar Recent Developments
8 Industry Chain Analysis
8.1 Next Generation Sequencing Industrial Chain
8.2 Next Generation Sequencing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Next Generation Sequencing Sales Model
8.5.2 Sales Channel
8.5.3 Next Generation Sequencing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Next Generation Sequencing Product Introduction
1.2 Global Next Generation Sequencing Market Size Forecast
1.3 Next Generation Sequencing Market Trends & Drivers
1.3.1 Next Generation Sequencing Industry Trends
1.3.2 Next Generation Sequencing Market Drivers & Opportunity
1.3.3 Next Generation Sequencing Market Challenges
1.3.4 Next Generation Sequencing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Next Generation Sequencing Players Revenue Ranking (2023)
2.2 Global Next Generation Sequencing Revenue by Company (2019-2024)
2.3 Key Companies Next Generation Sequencing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Next Generation Sequencing Product Offered
2.5 Key Companies Time to Begin Mass Production of Next Generation Sequencing
2.6 Next Generation Sequencing Market Competitive Analysis
2.6.1 Next Generation Sequencing Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Next Generation Sequencing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Sequencing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Targeted Sequencing & Resequencing
3.1.2 Whole Genome Sequencing
3.1.3 Whole Exome Sequencing
3.2 Global Next Generation Sequencing Sales Value by Type
3.2.1 Global Next Generation Sequencing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Next Generation Sequencing Sales Value, by Type (2019-2030)
3.2.3 Global Next Generation Sequencing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Whole-genome Sequencing
4.1.2 Exome Sequencing
4.1.3 Targeted Resequencing
4.1.4 De Novo Sequencing
4.1.5 RNA Sequencing
4.1.6 ChIP Sequencing
4.1.7 Methyl Sequencing
4.1.8 Others
4.2 Global Next Generation Sequencing Sales Value by Application
4.2.1 Global Next Generation Sequencing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Next Generation Sequencing Sales Value, by Application (2019-2030)
4.2.3 Global Next Generation Sequencing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Next Generation Sequencing Sales Value by Region
5.1.1 Global Next Generation Sequencing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Next Generation Sequencing Sales Value by Region (2019-2024)
5.1.3 Global Next Generation Sequencing Sales Value by Region (2025-2030)
5.1.4 Global Next Generation Sequencing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Next Generation Sequencing Sales Value, 2019-2030
5.2.2 North America Next Generation Sequencing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Next Generation Sequencing Sales Value, 2019-2030
5.3.2 Europe Next Generation Sequencing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Next Generation Sequencing Sales Value, 2019-2030
5.4.2 Asia Pacific Next Generation Sequencing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Next Generation Sequencing Sales Value, 2019-2030
5.5.2 South America Next Generation Sequencing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Next Generation Sequencing Sales Value, 2019-2030
5.6.2 Middle East & Africa Next Generation Sequencing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Next Generation Sequencing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Next Generation Sequencing Sales Value
6.3 United States
6.3.1 United States Next Generation Sequencing Sales Value, 2019-2030
6.3.2 United States Next Generation Sequencing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Next Generation Sequencing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Next Generation Sequencing Sales Value, 2019-2030
6.4.2 Europe Next Generation Sequencing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Next Generation Sequencing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Next Generation Sequencing Sales Value, 2019-2030
6.5.2 China Next Generation Sequencing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Next Generation Sequencing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Next Generation Sequencing Sales Value, 2019-2030
6.6.2 Japan Next Generation Sequencing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Next Generation Sequencing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Next Generation Sequencing Sales Value, 2019-2030
6.7.2 South Korea Next Generation Sequencing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Next Generation Sequencing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Next Generation Sequencing Sales Value, 2019-2030
6.8.2 Southeast Asia Next Generation Sequencing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Next Generation Sequencing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Next Generation Sequencing Sales Value, 2019-2030
6.9.2 India Next Generation Sequencing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Next Generation Sequencing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 454 Life Sciences Corporation (A Roche Company)
7.1.1 454 Life Sciences Corporation (A Roche Company) Profile
7.1.2 454 Life Sciences Corporation (A Roche Company) Main Business
7.1.3 454 Life Sciences Corporation (A Roche Company) Next Generation Sequencing Products, Services and Solutions
7.1.4 454 Life Sciences Corporation (A Roche Company) Next Generation Sequencing Revenue (US$ Million) & (2019-2024)
7.1.5 454 Life Sciences Corporation (A Roche Company) Recent Developments
7.2 Agilent Technologies
7.2.1 Agilent Technologies Profile
7.2.2 Agilent Technologies Main Business
7.2.3 Agilent Technologies Next Generation Sequencing Products, Services and Solutions
7.2.4 Agilent Technologies Next Generation Sequencing Revenue (US$ Million) & (2019-2024)
7.2.5 Agilent Technologies Recent Developments
7.3 Biomatters, Ltd
7.3.1 Biomatters, Ltd Profile
7.3.2 Biomatters, Ltd Main Business
7.3.3 Biomatters, Ltd Next Generation Sequencing Products, Services and Solutions
7.3.4 Biomatters, Ltd Next Generation Sequencing Revenue (US$ Million) & (2019-2024)
7.3.5 CLC Bio Recent Developments
7.4 CLC Bio
7.4.1 CLC Bio Profile
7.4.2 CLC Bio Main Business
7.4.3 CLC Bio Next Generation Sequencing Products, Services and Solutions
7.4.4 CLC Bio Next Generation Sequencing Revenue (US$ Million) & (2019-2024)
7.4.5 CLC Bio Recent Developments
7.5 GATC biotech AG
7.5.1 GATC biotech AG Profile
7.5.2 GATC biotech AG Main Business
7.5.3 GATC biotech AG Next Generation Sequencing Products, Services and Solutions
7.5.4 GATC biotech AG Next Generation Sequencing Revenue (US$ Million) & (2019-2024)
7.5.5 GATC biotech AG Recent Developments
7.6 Macrogen
7.6.1 Macrogen Profile
7.6.2 Macrogen Main Business
7.6.3 Macrogen Next Generation Sequencing Products, Services and Solutions
7.6.4 Macrogen Next Generation Sequencing Revenue (US$ Million) & (2019-2024)
7.6.5 Macrogen Recent Developments
7.7 BGI (Beijing Genomics Institute)
7.7.1 BGI (Beijing Genomics Institute) Profile
7.7.2 BGI (Beijing Genomics Institute) Main Business
7.7.3 BGI (Beijing Genomics Institute) Next Generation Sequencing Products, Services and Solutions
7.7.4 BGI (Beijing Genomics Institute) Next Generation Sequencing Revenue (US$ Million) & (2019-2024)
7.7.5 BGI (Beijing Genomics Institute) Recent Developments
7.8 Illumina
7.8.1 Illumina Profile
7.8.2 Illumina Main Business
7.8.3 Illumina Next Generation Sequencing Products, Services and Solutions
7.8.4 Illumina Next Generation Sequencing Revenue (US$ Million) & (2019-2024)
7.8.5 Illumina Recent Developments
7.9 Life Technology Corporation
7.9.1 Life Technology Corporation Profile
7.9.2 Life Technology Corporation Main Business
7.9.3 Life Technology Corporation Next Generation Sequencing Products, Services and Solutions
7.9.4 Life Technology Corporation Next Generation Sequencing Revenue (US$ Million) & (2019-2024)
7.9.5 Life Technology Corporation Recent Developments
7.10 EMC Corporation
7.10.1 EMC Corporation Profile
7.10.2 EMC Corporation Main Business
7.10.3 EMC Corporation Next Generation Sequencing Products, Services and Solutions
7.10.4 EMC Corporation Next Generation Sequencing Revenue (US$ Million) & (2019-2024)
7.10.5 EMC Corporation Recent Developments
7.11 Dnastar
7.11.1 Dnastar Profile
7.11.2 Dnastar Main Business
7.11.3 Dnastar Next Generation Sequencing Products, Services and Solutions
7.11.4 Dnastar Next Generation Sequencing Revenue (US$ Million) & (2019-2024)
7.11.5 Dnastar Recent Developments
8 Industry Chain Analysis
8.1 Next Generation Sequencing Industrial Chain
8.2 Next Generation Sequencing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Next Generation Sequencing Sales Model
8.5.2 Sales Channel
8.5.3 Next Generation Sequencing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Next Generation Sequencing Market Trends
Table 2. Next Generation Sequencing Market Drivers & Opportunity
Table 3. Next Generation Sequencing Market Challenges
Table 4. Next Generation Sequencing Market Restraints
Table 5. Global Next Generation Sequencing Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Next Generation Sequencing Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Next Generation Sequencing Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Next Generation Sequencing Product Type
Table 9. Key Companies Time to Begin Mass Production of Next Generation Sequencing
Table 10. Global Next Generation Sequencing Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Sequencing as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Next Generation Sequencing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Next Generation Sequencing Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Next Generation Sequencing Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Next Generation Sequencing Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Next Generation Sequencing Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Next Generation Sequencing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Next Generation Sequencing Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Next Generation Sequencing Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Next Generation Sequencing Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Next Generation Sequencing Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Next Generation Sequencing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Next Generation Sequencing Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Next Generation Sequencing Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Next Generation Sequencing Sales Value by Region (2019-2024) & (%)
Table 27. Global Next Generation Sequencing Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Next Generation Sequencing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Next Generation Sequencing Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Next Generation Sequencing Sales Value, (2025-2030) & (US$ Million)
Table 31. 454 Life Sciences Corporation (A Roche Company) Basic Information List
Table 32. 454 Life Sciences Corporation (A Roche Company) Description and Business Overview
Table 33. 454 Life Sciences Corporation (A Roche Company) Next Generation Sequencing Products, Services and Solutions
Table 34. Revenue (US$ Million) in Next Generation Sequencing Business of 454 Life Sciences Corporation (A Roche Company) (2019-2024)
Table 35. 454 Life Sciences Corporation (A Roche Company) Recent Developments
Table 36. Agilent Technologies Basic Information List
Table 37. Agilent Technologies Description and Business Overview
Table 38. Agilent Technologies Next Generation Sequencing Products, Services and Solutions
Table 39. Revenue (US$ Million) in Next Generation Sequencing Business of Agilent Technologies (2019-2024)
Table 40. Agilent Technologies Recent Developments
Table 41. Biomatters, Ltd Basic Information List
Table 42. Biomatters, Ltd Description and Business Overview
Table 43. Biomatters, Ltd Next Generation Sequencing Products, Services and Solutions
Table 44. Revenue (US$ Million) in Next Generation Sequencing Business of Biomatters, Ltd (2019-2024)
Table 45. Biomatters, Ltd Recent Developments
Table 46. CLC Bio Basic Information List
Table 47. CLC Bio Description and Business Overview
Table 48. CLC Bio Next Generation Sequencing Products, Services and Solutions
Table 49. Revenue (US$ Million) in Next Generation Sequencing Business of CLC Bio (2019-2024)
Table 50. CLC Bio Recent Developments
Table 51. GATC biotech AG Basic Information List
Table 52. GATC biotech AG Description and Business Overview
Table 53. GATC biotech AG Next Generation Sequencing Products, Services and Solutions
Table 54. Revenue (US$ Million) in Next Generation Sequencing Business of GATC biotech AG (2019-2024)
Table 55. GATC biotech AG Recent Developments
Table 56. Macrogen Basic Information List
Table 57. Macrogen Description and Business Overview
Table 58. Macrogen Next Generation Sequencing Products, Services and Solutions
Table 59. Revenue (US$ Million) in Next Generation Sequencing Business of Macrogen (2019-2024)
Table 60. Macrogen Recent Developments
Table 61. BGI (Beijing Genomics Institute) Basic Information List
Table 62. BGI (Beijing Genomics Institute) Description and Business Overview
Table 63. BGI (Beijing Genomics Institute) Next Generation Sequencing Products, Services and Solutions
Table 64. Revenue (US$ Million) in Next Generation Sequencing Business of BGI (Beijing Genomics Institute) (2019-2024)
Table 65. BGI (Beijing Genomics Institute) Recent Developments
Table 66. Illumina Basic Information List
Table 67. Illumina Description and Business Overview
Table 68. Illumina Next Generation Sequencing Products, Services and Solutions
Table 69. Revenue (US$ Million) in Next Generation Sequencing Business of Illumina (2019-2024)
Table 70. Illumina Recent Developments
Table 71. Life Technology Corporation Basic Information List
Table 72. Life Technology Corporation Description and Business Overview
Table 73. Life Technology Corporation Next Generation Sequencing Products, Services and Solutions
Table 74. Revenue (US$ Million) in Next Generation Sequencing Business of Life Technology Corporation (2019-2024)
Table 75. Life Technology Corporation Recent Developments
Table 76. EMC Corporation Basic Information List
Table 77. EMC Corporation Description and Business Overview
Table 78. EMC Corporation Next Generation Sequencing Products, Services and Solutions
Table 79. Revenue (US$ Million) in Next Generation Sequencing Business of EMC Corporation (2019-2024)
Table 80. EMC Corporation Recent Developments
Table 81. Dnastar Basic Information List
Table 82. Dnastar Description and Business Overview
Table 83. Dnastar Next Generation Sequencing Products, Services and Solutions
Table 84. Revenue (US$ Million) in Next Generation Sequencing Business of Dnastar (2019-2024)
Table 85. Dnastar Recent Developments
Table 86. Key Raw Materials Lists
Table 87. Raw Materials Key Suppliers Lists
Table 88. Next Generation Sequencing Downstream Customers
Table 89. Next Generation Sequencing Distributors List
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
Table 93. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Next Generation Sequencing Product Picture
Figure 2. Global Next Generation Sequencing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Next Generation Sequencing Sales Value (2019-2030) & (US$ Million)
Figure 4. Next Generation Sequencing Report Years Considered
Figure 5. Global Next Generation Sequencing Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Next Generation Sequencing Revenue in 2023
Figure 7. Next Generation Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Targeted Sequencing & Resequencing Picture
Figure 9. Whole Genome Sequencing Picture
Figure 10. Whole Exome Sequencing Picture
Figure 11. Global Next Generation Sequencing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Next Generation Sequencing Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Whole-genome Sequencing
Figure 14. Product Picture of Exome Sequencing
Figure 15. Product Picture of Targeted Resequencing
Figure 16. Product Picture of De Novo Sequencing
Figure 17. Product Picture of RNA Sequencing
Figure 18. Product Picture of ChIP Sequencing
Figure 19. Product Picture of Methyl Sequencing
Figure 20. Product Picture of Others
Figure 21. Global Next Generation Sequencing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Next Generation Sequencing Sales Value Market Share by Application, 2023 & 2030
Figure 23. North America Next Generation Sequencing Sales Value (2019-2030) & (US$ Million)
Figure 24. North America Next Generation Sequencing Sales Value by Country (%), 2023 VS 2030
Figure 25. Europe Next Generation Sequencing Sales Value (2019-2030) & (US$ Million)
Figure 26. Europe Next Generation Sequencing Sales Value by Country (%), 2023 VS 2030
Figure 27. Asia Pacific Next Generation Sequencing Sales Value (2019-2030) & (US$ Million)
Figure 28. Asia Pacific Next Generation Sequencing Sales Value by Country (%), 2023 VS 2030
Figure 29. South America Next Generation Sequencing Sales Value (2019-2030) & (US$ Million)
Figure 30. South America Next Generation Sequencing Sales Value by Country (%), 2023 VS 2030
Figure 31. Middle East & Africa Next Generation Sequencing Sales Value (2019-2030) & (US$ Million)
Figure 32. Middle East & Africa Next Generation Sequencing Sales Value by Country (%), 2023 VS 2030
Figure 33. Key Countries/Regions Next Generation Sequencing Sales Value (%), (2019-2030)
Figure 34. United States Next Generation Sequencing Sales Value, (2019-2030) & (US$ Million)
Figure 35. United States Next Generation Sequencing Sales Value by Type (%), 2023 VS 2030
Figure 36. United States Next Generation Sequencing Sales Value by Application (%), 2023 VS 2030
Figure 37. Europe Next Generation Sequencing Sales Value, (2019-2030) & (US$ Million)
Figure 38. Europe Next Generation Sequencing Sales Value by Type (%), 2023 VS 2030
Figure 39. Europe Next Generation Sequencing Sales Value by Application (%), 2023 VS 2030
Figure 40. China Next Generation Sequencing Sales Value, (2019-2030) & (US$ Million)
Figure 41. China Next Generation Sequencing Sales Value by Type (%), 2023 VS 2030
Figure 42. China Next Generation Sequencing Sales Value by Application (%), 2023 VS 2030
Figure 43. Japan Next Generation Sequencing Sales Value, (2019-2030) & (US$ Million)
Figure 44. Japan Next Generation Sequencing Sales Value by Type (%), 2023 VS 2030
Figure 45. Japan Next Generation Sequencing Sales Value by Application (%), 2023 VS 2030
Figure 46. South Korea Next Generation Sequencing Sales Value, (2019-2030) & (US$ Million)
Figure 47. South Korea Next Generation Sequencing Sales Value by Type (%), 2023 VS 2030
Figure 48. South Korea Next Generation Sequencing Sales Value by Application (%), 2023 VS 2030
Figure 49. Southeast Asia Next Generation Sequencing Sales Value, (2019-2030) & (US$ Million)
Figure 50. Southeast Asia Next Generation Sequencing Sales Value by Type (%), 2023 VS 2030
Figure 51. Southeast Asia Next Generation Sequencing Sales Value by Application (%), 2023 VS 2030
Figure 52. India Next Generation Sequencing Sales Value, (2019-2030) & (US$ Million)
Figure 53. India Next Generation Sequencing Sales Value by Type (%), 2023 VS 2030
Figure 54. India Next Generation Sequencing Sales Value by Application (%), 2023 VS 2030
Figure 55. Next Generation Sequencing Industrial Chain
Figure 56. Next Generation Sequencing Manufacturing Cost Structure
Figure 57. Channels of Distribution (Direct Sales, and Distribution)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Table 1. Next Generation Sequencing Market Trends
Table 2. Next Generation Sequencing Market Drivers & Opportunity
Table 3. Next Generation Sequencing Market Challenges
Table 4. Next Generation Sequencing Market Restraints
Table 5. Global Next Generation Sequencing Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Next Generation Sequencing Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Next Generation Sequencing Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Next Generation Sequencing Product Type
Table 9. Key Companies Time to Begin Mass Production of Next Generation Sequencing
Table 10. Global Next Generation Sequencing Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Sequencing as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Next Generation Sequencing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Next Generation Sequencing Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Next Generation Sequencing Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Next Generation Sequencing Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Next Generation Sequencing Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Next Generation Sequencing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Next Generation Sequencing Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Next Generation Sequencing Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Next Generation Sequencing Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Next Generation Sequencing Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Next Generation Sequencing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Next Generation Sequencing Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Next Generation Sequencing Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Next Generation Sequencing Sales Value by Region (2019-2024) & (%)
Table 27. Global Next Generation Sequencing Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Next Generation Sequencing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Next Generation Sequencing Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Next Generation Sequencing Sales Value, (2025-2030) & (US$ Million)
Table 31. 454 Life Sciences Corporation (A Roche Company) Basic Information List
Table 32. 454 Life Sciences Corporation (A Roche Company) Description and Business Overview
Table 33. 454 Life Sciences Corporation (A Roche Company) Next Generation Sequencing Products, Services and Solutions
Table 34. Revenue (US$ Million) in Next Generation Sequencing Business of 454 Life Sciences Corporation (A Roche Company) (2019-2024)
Table 35. 454 Life Sciences Corporation (A Roche Company) Recent Developments
Table 36. Agilent Technologies Basic Information List
Table 37. Agilent Technologies Description and Business Overview
Table 38. Agilent Technologies Next Generation Sequencing Products, Services and Solutions
Table 39. Revenue (US$ Million) in Next Generation Sequencing Business of Agilent Technologies (2019-2024)
Table 40. Agilent Technologies Recent Developments
Table 41. Biomatters, Ltd Basic Information List
Table 42. Biomatters, Ltd Description and Business Overview
Table 43. Biomatters, Ltd Next Generation Sequencing Products, Services and Solutions
Table 44. Revenue (US$ Million) in Next Generation Sequencing Business of Biomatters, Ltd (2019-2024)
Table 45. Biomatters, Ltd Recent Developments
Table 46. CLC Bio Basic Information List
Table 47. CLC Bio Description and Business Overview
Table 48. CLC Bio Next Generation Sequencing Products, Services and Solutions
Table 49. Revenue (US$ Million) in Next Generation Sequencing Business of CLC Bio (2019-2024)
Table 50. CLC Bio Recent Developments
Table 51. GATC biotech AG Basic Information List
Table 52. GATC biotech AG Description and Business Overview
Table 53. GATC biotech AG Next Generation Sequencing Products, Services and Solutions
Table 54. Revenue (US$ Million) in Next Generation Sequencing Business of GATC biotech AG (2019-2024)
Table 55. GATC biotech AG Recent Developments
Table 56. Macrogen Basic Information List
Table 57. Macrogen Description and Business Overview
Table 58. Macrogen Next Generation Sequencing Products, Services and Solutions
Table 59. Revenue (US$ Million) in Next Generation Sequencing Business of Macrogen (2019-2024)
Table 60. Macrogen Recent Developments
Table 61. BGI (Beijing Genomics Institute) Basic Information List
Table 62. BGI (Beijing Genomics Institute) Description and Business Overview
Table 63. BGI (Beijing Genomics Institute) Next Generation Sequencing Products, Services and Solutions
Table 64. Revenue (US$ Million) in Next Generation Sequencing Business of BGI (Beijing Genomics Institute) (2019-2024)
Table 65. BGI (Beijing Genomics Institute) Recent Developments
Table 66. Illumina Basic Information List
Table 67. Illumina Description and Business Overview
Table 68. Illumina Next Generation Sequencing Products, Services and Solutions
Table 69. Revenue (US$ Million) in Next Generation Sequencing Business of Illumina (2019-2024)
Table 70. Illumina Recent Developments
Table 71. Life Technology Corporation Basic Information List
Table 72. Life Technology Corporation Description and Business Overview
Table 73. Life Technology Corporation Next Generation Sequencing Products, Services and Solutions
Table 74. Revenue (US$ Million) in Next Generation Sequencing Business of Life Technology Corporation (2019-2024)
Table 75. Life Technology Corporation Recent Developments
Table 76. EMC Corporation Basic Information List
Table 77. EMC Corporation Description and Business Overview
Table 78. EMC Corporation Next Generation Sequencing Products, Services and Solutions
Table 79. Revenue (US$ Million) in Next Generation Sequencing Business of EMC Corporation (2019-2024)
Table 80. EMC Corporation Recent Developments
Table 81. Dnastar Basic Information List
Table 82. Dnastar Description and Business Overview
Table 83. Dnastar Next Generation Sequencing Products, Services and Solutions
Table 84. Revenue (US$ Million) in Next Generation Sequencing Business of Dnastar (2019-2024)
Table 85. Dnastar Recent Developments
Table 86. Key Raw Materials Lists
Table 87. Raw Materials Key Suppliers Lists
Table 88. Next Generation Sequencing Downstream Customers
Table 89. Next Generation Sequencing Distributors List
Table 90. Research Programs/Design for This Report
Table 91. Key Data Information from Secondary Sources
Table 92. Key Data Information from Primary Sources
Table 93. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Next Generation Sequencing Product Picture
Figure 2. Global Next Generation Sequencing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Next Generation Sequencing Sales Value (2019-2030) & (US$ Million)
Figure 4. Next Generation Sequencing Report Years Considered
Figure 5. Global Next Generation Sequencing Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Next Generation Sequencing Revenue in 2023
Figure 7. Next Generation Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Targeted Sequencing & Resequencing Picture
Figure 9. Whole Genome Sequencing Picture
Figure 10. Whole Exome Sequencing Picture
Figure 11. Global Next Generation Sequencing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Next Generation Sequencing Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Whole-genome Sequencing
Figure 14. Product Picture of Exome Sequencing
Figure 15. Product Picture of Targeted Resequencing
Figure 16. Product Picture of De Novo Sequencing
Figure 17. Product Picture of RNA Sequencing
Figure 18. Product Picture of ChIP Sequencing
Figure 19. Product Picture of Methyl Sequencing
Figure 20. Product Picture of Others
Figure 21. Global Next Generation Sequencing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Next Generation Sequencing Sales Value Market Share by Application, 2023 & 2030
Figure 23. North America Next Generation Sequencing Sales Value (2019-2030) & (US$ Million)
Figure 24. North America Next Generation Sequencing Sales Value by Country (%), 2023 VS 2030
Figure 25. Europe Next Generation Sequencing Sales Value (2019-2030) & (US$ Million)
Figure 26. Europe Next Generation Sequencing Sales Value by Country (%), 2023 VS 2030
Figure 27. Asia Pacific Next Generation Sequencing Sales Value (2019-2030) & (US$ Million)
Figure 28. Asia Pacific Next Generation Sequencing Sales Value by Country (%), 2023 VS 2030
Figure 29. South America Next Generation Sequencing Sales Value (2019-2030) & (US$ Million)
Figure 30. South America Next Generation Sequencing Sales Value by Country (%), 2023 VS 2030
Figure 31. Middle East & Africa Next Generation Sequencing Sales Value (2019-2030) & (US$ Million)
Figure 32. Middle East & Africa Next Generation Sequencing Sales Value by Country (%), 2023 VS 2030
Figure 33. Key Countries/Regions Next Generation Sequencing Sales Value (%), (2019-2030)
Figure 34. United States Next Generation Sequencing Sales Value, (2019-2030) & (US$ Million)
Figure 35. United States Next Generation Sequencing Sales Value by Type (%), 2023 VS 2030
Figure 36. United States Next Generation Sequencing Sales Value by Application (%), 2023 VS 2030
Figure 37. Europe Next Generation Sequencing Sales Value, (2019-2030) & (US$ Million)
Figure 38. Europe Next Generation Sequencing Sales Value by Type (%), 2023 VS 2030
Figure 39. Europe Next Generation Sequencing Sales Value by Application (%), 2023 VS 2030
Figure 40. China Next Generation Sequencing Sales Value, (2019-2030) & (US$ Million)
Figure 41. China Next Generation Sequencing Sales Value by Type (%), 2023 VS 2030
Figure 42. China Next Generation Sequencing Sales Value by Application (%), 2023 VS 2030
Figure 43. Japan Next Generation Sequencing Sales Value, (2019-2030) & (US$ Million)
Figure 44. Japan Next Generation Sequencing Sales Value by Type (%), 2023 VS 2030
Figure 45. Japan Next Generation Sequencing Sales Value by Application (%), 2023 VS 2030
Figure 46. South Korea Next Generation Sequencing Sales Value, (2019-2030) & (US$ Million)
Figure 47. South Korea Next Generation Sequencing Sales Value by Type (%), 2023 VS 2030
Figure 48. South Korea Next Generation Sequencing Sales Value by Application (%), 2023 VS 2030
Figure 49. Southeast Asia Next Generation Sequencing Sales Value, (2019-2030) & (US$ Million)
Figure 50. Southeast Asia Next Generation Sequencing Sales Value by Type (%), 2023 VS 2030
Figure 51. Southeast Asia Next Generation Sequencing Sales Value by Application (%), 2023 VS 2030
Figure 52. India Next Generation Sequencing Sales Value, (2019-2030) & (US$ Million)
Figure 53. India Next Generation Sequencing Sales Value by Type (%), 2023 VS 2030
Figure 54. India Next Generation Sequencing Sales Value by Application (%), 2023 VS 2030
Figure 55. Next Generation Sequencing Industrial Chain
Figure 56. Next Generation Sequencing Manufacturing Cost Structure
Figure 57. Channels of Distribution (Direct Sales, and Distribution)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232